nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ERBB2—mouth—Behcet's disease	0.0337	0.0606	CbGeAlD
Afatinib—PHKG2—brainstem—Behcet's disease	0.0245	0.044	CbGeAlD
Afatinib—ERBB4—brainstem—Behcet's disease	0.022	0.0396	CbGeAlD
Afatinib—DYRK1A—brainstem—Behcet's disease	0.0212	0.0381	CbGeAlD
Afatinib—ERBB2—skin of body—Behcet's disease	0.0186	0.0335	CbGeAlD
Afatinib—PHKG2—medulla oblongata—Behcet's disease	0.0171	0.0307	CbGeAlD
Afatinib—ERBB4—cardiac atrium—Behcet's disease	0.0163	0.0293	CbGeAlD
Afatinib—ERBB4—medulla oblongata—Behcet's disease	0.0153	0.0276	CbGeAlD
Afatinib—EGFR—mammalian vulva—Behcet's disease	0.0144	0.0259	CbGeAlD
Afatinib—ERBB4—midbrain—Behcet's disease	0.014	0.0252	CbGeAlD
Afatinib—ERBB4—spinal cord—Behcet's disease	0.0137	0.0246	CbGeAlD
Afatinib—EPHA6—nervous system—Behcet's disease	0.0133	0.0239	CbGeAlD
Afatinib—HIPK4—brain—Behcet's disease	0.0129	0.0231	CbGeAlD
Afatinib—PHKG2—nervous system—Behcet's disease	0.0128	0.0231	CbGeAlD
Afatinib—EPHA6—central nervous system—Behcet's disease	0.0128	0.023	CbGeAlD
Afatinib—IRAK1—mammalian vulva—Behcet's disease	0.0127	0.0229	CbGeAlD
Afatinib—LCK—mammalian vulva—Behcet's disease	0.0124	0.0223	CbGeAlD
Afatinib—PHKG2—central nervous system—Behcet's disease	0.0123	0.0222	CbGeAlD
Afatinib—ERBB2—nervous system—Behcet's disease	0.0115	0.0207	CbGeAlD
Afatinib—ERBB4—nervous system—Behcet's disease	0.0115	0.0207	CbGeAlD
Afatinib—ERBB2—central nervous system—Behcet's disease	0.0111	0.02	CbGeAlD
Afatinib—ERBB4—central nervous system—Behcet's disease	0.0111	0.02	CbGeAlD
Afatinib—DYRK1A—nervous system—Behcet's disease	0.0111	0.02	CbGeAlD
Afatinib—DYRK1A—central nervous system—Behcet's disease	0.0107	0.0192	CbGeAlD
Afatinib—IRAK1—midbrain—Behcet's disease	0.0105	0.0189	CbGeAlD
Afatinib—EPHA6—brain—Behcet's disease	0.0102	0.0183	CbGeAlD
Afatinib—PHKG2—brain—Behcet's disease	0.0098	0.0176	CbGeAlD
Afatinib—ABL1—brainstem—Behcet's disease	0.00922	0.0166	CbGeAlD
Afatinib—ABL1—eye—Behcet's disease	0.00897	0.0161	CbGeAlD
Afatinib—ABL1—retina—Behcet's disease	0.00889	0.016	CbGeAlD
Afatinib—ERBB4—brain—Behcet's disease	0.00881	0.0159	CbGeAlD
Afatinib—ERBB2—brain—Behcet's disease	0.00881	0.0159	CbGeAlD
Afatinib—DYRK1A—brain—Behcet's disease	0.00848	0.0153	CbGeAlD
Afatinib—ABL1—skin of body—Behcet's disease	0.00781	0.014	CbGeAlD
Afatinib—EGFR—brain—Behcet's disease	0.00747	0.0134	CbGeAlD
Afatinib—ABL1—mammalian vulva—Behcet's disease	0.00712	0.0128	CbGeAlD
Afatinib—ABL1—cardiac atrium—Behcet's disease	0.00682	0.0123	CbGeAlD
Afatinib—IRAK1—brain—Behcet's disease	0.00659	0.0119	CbGeAlD
Afatinib—ABL1—medulla oblongata—Behcet's disease	0.00643	0.0116	CbGeAlD
Afatinib—ABL1—midbrain—Behcet's disease	0.00587	0.0106	CbGeAlD
Afatinib—ABL1—spinal cord—Behcet's disease	0.00573	0.0103	CbGeAlD
Afatinib—ABCB1—blood vessel—Behcet's disease	0.00524	0.00944	CbGeAlD
Afatinib—LCK—Interferon type I signaling pathways—STAT4—Behcet's disease	0.00511	0.0115	CbGpPWpGaD
Afatinib—IRAK1—Toll-Like Receptors Cascades—ITGB2—Behcet's disease	0.00511	0.0115	CbGpPWpGaD
Afatinib—ERBB2—Focal Adhesion—ITGAL—Behcet's disease	0.00502	0.0113	CbGpPWpGaD
Afatinib—ABL1—nervous system—Behcet's disease	0.00483	0.00869	CbGeAlD
Afatinib—BLK—Focal Adhesion—ITGAL—Behcet's disease	0.00475	0.0107	CbGpPWpGaD
Afatinib—LCK—IL12-mediated signaling events—STAT4—Behcet's disease	0.0047	0.0106	CbGpPWpGaD
Afatinib—ABL1—central nervous system—Behcet's disease	0.00465	0.00837	CbGeAlD
Afatinib—ABCG2—mammalian vulva—Behcet's disease	0.00449	0.00808	CbGeAlD
Afatinib—ERBB2—DNA Damage Response (only ATM dependent)—CAT—Behcet's disease	0.00444	0.00998	CbGpPWpGaD
Afatinib—LCK—Cell surface interactions at the vascular wall—ITGB2—Behcet's disease	0.00437	0.00983	CbGpPWpGaD
Afatinib—BLK—Thromboxane A2 receptor signaling—NOS3—Behcet's disease	0.00417	0.00938	CbGpPWpGaD
Afatinib—EGFR—Syndecan-3-mediated signaling events—CXCL8—Behcet's disease	0.00413	0.0093	CbGpPWpGaD
Afatinib—ABCG2—medulla oblongata—Behcet's disease	0.00405	0.00729	CbGeAlD
Afatinib—IRAK1—EBV LMP1 signaling—TNF—Behcet's disease	0.004	0.009	CbGpPWpGaD
Afatinib—LCK—Cell surface interactions at the vascular wall—ITGAL—Behcet's disease	0.00394	0.00886	CbGpPWpGaD
Afatinib—ABCG2—midbrain—Behcet's disease	0.0037	0.00667	CbGeAlD
Afatinib—ABL1—brain—Behcet's disease	0.00369	0.00664	CbGeAlD
Afatinib—LCK—Costimulation by the CD28 family—CTLA4—Behcet's disease	0.00366	0.00824	CbGpPWpGaD
Afatinib—ABCG2—spinal cord—Behcet's disease	0.00361	0.0065	CbGeAlD
Afatinib—ERBB2—Leptin signaling pathway—NOS3—Behcet's disease	0.00348	0.00784	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—MEFV—Behcet's disease	0.00347	0.00781	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—MEFV—Behcet's disease	0.00342	0.00769	CbGpPWpGaD
Afatinib—DYRK1A—Circadian rythm related genes—SERPINE1—Behcet's disease	0.00334	0.00752	CbGpPWpGaD
Afatinib—ABCB1—HIF-1-alpha transcription factor network—ITGB2—Behcet's disease	0.00316	0.00712	CbGpPWpGaD
Afatinib—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—Behcet's disease	0.0031	0.00698	CbGpPWpGaD
Afatinib—EGFR—Bladder Cancer—CXCL8—Behcet's disease	0.00303	0.00681	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—ERAP1—Behcet's disease	0.00297	0.00668	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—ERAP1—Behcet's disease	0.00293	0.00658	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—ERAP1—Behcet's disease	0.00281	0.00633	CbGpPWpGaD
Afatinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—Behcet's disease	0.0028	0.00631	CbGpPWpGaD
Afatinib—ABCB1—retina—Behcet's disease	0.00276	0.00498	CbGeAlD
Afatinib—ERBB2—DAP12 interactions—HLA-B—Behcet's disease	0.0027	0.00608	CbGpPWpGaD
Afatinib—EGFR—Focal Adhesion—ITGB2—Behcet's disease	0.00269	0.00605	CbGpPWpGaD
Afatinib—EGFR—Thromboxane A2 receptor signaling—ICAM1—Behcet's disease	0.00267	0.006	CbGpPWpGaD
Afatinib—ERBB4—DAP12 interactions—HLA-B—Behcet's disease	0.00266	0.00599	CbGpPWpGaD
Afatinib—LCK—Thromboxane A2 receptor signaling—ICAM1—Behcet's disease	0.00257	0.00578	CbGpPWpGaD
Afatinib—ABL1—DNA Damage Response (only ATM dependent)—CAT—Behcet's disease	0.00251	0.00565	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—MEFV—Behcet's disease	0.00251	0.00565	CbGpPWpGaD
Afatinib—EGFR—Focal Adhesion—ITGAL—Behcet's disease	0.00243	0.00546	CbGpPWpGaD
Afatinib—ABCG2—brain—Behcet's disease	0.00233	0.00419	CbGeAlD
Afatinib—ERBB2—Innate Immune System—ITGB2—Behcet's disease	0.00229	0.00515	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—ITGB2—Behcet's disease	0.00225	0.00507	CbGpPWpGaD
Afatinib—ABCB1—mammalian vulva—Behcet's disease	0.00221	0.00398	CbGeAlD
Afatinib—ERBB2—Adaptive Immune System—ITGB2—Behcet's disease	0.0022	0.00494	CbGpPWpGaD
Afatinib—LCK—Cell surface interactions at the vascular wall—APOB—Behcet's disease	0.00217	0.00488	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—ITGB2—Behcet's disease	0.00216	0.00487	CbGpPWpGaD
Afatinib—EGFR—Thromboxane A2 receptor signaling—NOS3—Behcet's disease	0.00213	0.00479	CbGpPWpGaD
Afatinib—LCK—TSLP Signaling Pathway—CXCL8—Behcet's disease	0.00209	0.00471	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—ITGB2—Behcet's disease	0.00208	0.00468	CbGpPWpGaD
Afatinib—EGFR—SHP2 signaling—NOS3—Behcet's disease	0.00207	0.00465	CbGpPWpGaD
Afatinib—LCK—Thromboxane A2 receptor signaling—NOS3—Behcet's disease	0.00205	0.00461	CbGpPWpGaD
Afatinib—ERBB2—Immune System—MEFV—Behcet's disease	0.00202	0.00455	CbGpPWpGaD
Afatinib—ABCB1—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.00202	0.00454	CbGpPWpGaD
Afatinib—ABCB1—medulla oblongata—Behcet's disease	0.002	0.0036	CbGeAlD
Afatinib—LCK—SHP2 signaling—NOS3—Behcet's disease	0.00199	0.00448	CbGpPWpGaD
Afatinib—ERBB4—Immune System—MEFV—Behcet's disease	0.00199	0.00448	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—ITGAL—Behcet's disease	0.00198	0.00446	CbGpPWpGaD
Afatinib—ABL1—p73 transcription factor network—SERPINE1—Behcet's disease	0.00198	0.00445	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—MEFV—Behcet's disease	0.00196	0.00442	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—ITGAL—Behcet's disease	0.00195	0.00439	CbGpPWpGaD
Afatinib—BLK—Immune System—MEFV—Behcet's disease	0.00191	0.00431	CbGpPWpGaD
Afatinib—ERBB2—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.00188	0.00423	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—ITGAL—Behcet's disease	0.00188	0.00422	CbGpPWpGaD
Afatinib—EGFR—AGE/RAGE pathway—NOS3—Behcet's disease	0.00186	0.0042	CbGpPWpGaD
Afatinib—ABCB1—midbrain—Behcet's disease	0.00183	0.00329	CbGeAlD
Afatinib—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.00182	0.0041	CbGpPWpGaD
Afatinib—ERBB2—Immune System—ERAP1—Behcet's disease	0.0018	0.00405	CbGpPWpGaD
Afatinib—ABCB1—spinal cord—Behcet's disease	0.00178	0.00321	CbGeAlD
Afatinib—ERBB4—Immune System—ERAP1—Behcet's disease	0.00177	0.00399	CbGpPWpGaD
Afatinib—IRAK1—Toll-like Receptor Signaling Pathway—CXCL8—Behcet's disease	0.00175	0.00393	CbGpPWpGaD
Afatinib—BLK—Immune System—ERAP1—Behcet's disease	0.00171	0.00384	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—CTLA4—Behcet's disease	0.0017	0.00383	CbGpPWpGaD
Afatinib—EGFR—LPA receptor mediated events—CXCL8—Behcet's disease	0.0017	0.00381	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—MEFV—Behcet's disease	0.00168	0.00377	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—ITGB2—Behcet's disease	0.00165	0.00372	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—MEFV—Behcet's disease	0.00162	0.00364	CbGpPWpGaD
Afatinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—Behcet's disease	0.00161	0.00361	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.00154	0.00346	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.00154	0.00346	CbGpPWpGaD
Afatinib—ABCB1—nervous system—Behcet's disease	0.0015	0.0027	CbGeAlD
Afatinib—EGFR—Spinal Cord Injury—ICAM1—Behcet's disease	0.00147	0.0033	CbGpPWpGaD
Afatinib—IRAK1—Immune System—MEFV—Behcet's disease	0.00146	0.00329	CbGpPWpGaD
Afatinib—ABCB1—central nervous system—Behcet's disease	0.00145	0.0026	CbGeAlD
Afatinib—ABL1—Hemostasis—ITGB2—Behcet's disease	0.00144	0.00323	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—ERAP1—Behcet's disease	0.00144	0.00323	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—ERAP1—Behcet's disease	0.00138	0.00311	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—CTLA4—Behcet's disease	0.00136	0.00307	CbGpPWpGaD
Afatinib—IRAK1—Regulation of toll-like receptor signaling pathway—CXCL8—Behcet's disease	0.00136	0.00307	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.00135	0.00305	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—CTLA4—Behcet's disease	0.00134	0.00302	CbGpPWpGaD
Afatinib—ERBB2—Immune System—ITGB2—Behcet's disease	0.00133	0.003	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—IL10—Behcet's disease	0.00132	0.00298	CbGpPWpGaD
Afatinib—ERBB4—Immune System—ITGB2—Behcet's disease	0.00131	0.00295	CbGpPWpGaD
Afatinib—EGFR—DAP12 interactions—HLA-B—Behcet's disease	0.00131	0.00294	CbGpPWpGaD
Afatinib—IRAK1—Immune System—ERAP1—Behcet's disease	0.0013	0.00293	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—ITGAL—Behcet's disease	0.0013	0.00292	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—ITGB2—Behcet's disease	0.00129	0.00291	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—CTLA4—Behcet's disease	0.00129	0.00291	CbGpPWpGaD
Afatinib—BLK—Immune System—ITGB2—Behcet's disease	0.00126	0.00284	CbGpPWpGaD
Afatinib—LCK—DAP12 interactions—HLA-B—Behcet's disease	0.00126	0.00283	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—HLA-B—Behcet's disease	0.00126	0.00283	CbGpPWpGaD
Afatinib—PHKG2—Disease—APOB—Behcet's disease	0.00123	0.00277	CbGpPWpGaD
Afatinib—IRAK1—Toll-like Receptor Signaling Pathway—TNF—Behcet's disease	0.00122	0.00274	CbGpPWpGaD
Afatinib—ERBB2—Immune System—ITGAL—Behcet's disease	0.0012	0.0027	CbGpPWpGaD
Afatinib—ERBB4—Immune System—ITGAL—Behcet's disease	0.00118	0.00266	CbGpPWpGaD
Afatinib—LCK—Hemostasis—ITGB2—Behcet's disease	0.00118	0.00266	CbGpPWpGaD
Afatinib—ABCB1—brain—Behcet's disease	0.00115	0.00207	CbGeAlD
Afatinib—ABL1—Immune System—MEFV—Behcet's disease	0.00114	0.00257	CbGpPWpGaD
Afatinib—BLK—Immune System—ITGAL—Behcet's disease	0.00114	0.00256	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—ITGB2—Behcet's disease	0.00111	0.00249	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.0011	0.00248	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—SERPINE1—Behcet's disease	0.00107	0.00241	CbGpPWpGaD
Afatinib—LCK—Hemostasis—ITGAL—Behcet's disease	0.00107	0.0024	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—ITGB2—Behcet's disease	0.00107	0.0024	CbGpPWpGaD
Afatinib—ABL1—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.00106	0.00239	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—CAT—Behcet's disease	0.00106	0.00239	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—ITGB2—Behcet's disease	0.00106	0.00239	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—HLA-B—Behcet's disease	0.00105	0.00236	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—CXCL8—Behcet's disease	0.00104	0.00234	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—HLA-B—Behcet's disease	0.00103	0.00233	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—APOB—Behcet's disease	0.00103	0.00232	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—ITGB2—Behcet's disease	0.00102	0.0023	CbGpPWpGaD
Afatinib—ABL1—Immune System—ERAP1—Behcet's disease	0.00102	0.00229	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.00102	0.00229	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—HLA-B—Behcet's disease	0.00101	0.00227	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—HLA-B—Behcet's disease	0.000994	0.00224	CbGpPWpGaD
Afatinib—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.000986	0.00222	CbGpPWpGaD
Afatinib—EGFR—Immune System—MEFV—Behcet's disease	0.000977	0.0022	CbGpPWpGaD
Afatinib—PHKG2—Disease—APOA1—Behcet's disease	0.000974	0.00219	CbGpPWpGaD
Afatinib—IRAK1—Immune System—ITGB2—Behcet's disease	0.000963	0.00217	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—ITGAL—Behcet's disease	0.000958	0.00216	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—HLA-B—Behcet's disease	0.000956	0.00215	CbGpPWpGaD
Afatinib—IRAK1—Regulation of toll-like receptor signaling pathway—TNF—Behcet's disease	0.000949	0.00214	CbGpPWpGaD
Afatinib—LCK—Immune System—MEFV—Behcet's disease	0.000942	0.00212	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—ITGAL—Behcet's disease	0.000923	0.00208	CbGpPWpGaD
Afatinib—EGFR—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.000909	0.00205	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CCR1—Behcet's disease	0.000906	0.00204	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.000902	0.00203	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CCR1—Behcet's disease	0.000892	0.00201	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.000873	0.00196	CbGpPWpGaD
Afatinib—EGFR—Immune System—ERAP1—Behcet's disease	0.000871	0.00196	CbGpPWpGaD
Afatinib—IRAK1—Immune System—ITGAL—Behcet's disease	0.000869	0.00196	CbGpPWpGaD
Afatinib—LCK—Immune System—ERAP1—Behcet's disease	0.000839	0.00189	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CTLA4—Behcet's disease	0.000827	0.00186	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—ICAM1—Behcet's disease	0.000819	0.00184	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—APOA1—Behcet's disease	0.000816	0.00184	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CTLA4—Behcet's disease	0.000815	0.00183	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—ICAM1—Behcet's disease	0.000807	0.00182	CbGpPWpGaD
Afatinib—BLK—Immune System—CTLA4—Behcet's disease	0.000784	0.00176	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—ICAM1—Behcet's disease	0.000776	0.00175	CbGpPWpGaD
Afatinib—PHKG2—Disease—SERPINE1—Behcet's disease	0.000773	0.00174	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—HLA-B—Behcet's disease	0.000759	0.00171	CbGpPWpGaD
Afatinib—ABL1—Immune System—ITGB2—Behcet's disease	0.000754	0.0017	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CCR1—Behcet's disease	0.000741	0.00167	CbGpPWpGaD
Afatinib—PHKG2—Disease—NOS3—Behcet's disease	0.000738	0.00166	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—TNF—Behcet's disease	0.000723	0.00163	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—CXCL8—Behcet's disease	0.000723	0.00163	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000716	0.00161	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—APOB—Behcet's disease	0.000713	0.00161	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000709	0.0016	CbGpPWpGaD
Afatinib—ABL1—Immune System—ITGAL—Behcet's disease	0.00068	0.00153	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CTLA4—Behcet's disease	0.000659	0.00148	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CCR1—Behcet's disease	0.000655	0.00147	CbGpPWpGaD
Afatinib—EGFR—Immune System—ITGB2—Behcet's disease	0.000644	0.00145	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—TNF—Behcet's disease	0.000643	0.00145	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CTLA4—Behcet's disease	0.000635	0.00143	CbGpPWpGaD
Afatinib—LCK—Immune System—ITGB2—Behcet's disease	0.000621	0.0014	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—NOS3—Behcet's disease	0.000618	0.00139	CbGpPWpGaD
Afatinib—ERBB2—Immune System—HLA-B—Behcet's disease	0.000612	0.00138	CbGpPWpGaD
Afatinib—ERBB2—Disease—APOB—Behcet's disease	0.00061	0.00137	CbGpPWpGaD
Afatinib—ERBB4—Immune System—HLA-B—Behcet's disease	0.000603	0.00136	CbGpPWpGaD
Afatinib—ERBB4—Disease—APOB—Behcet's disease	0.000601	0.00135	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CTLA4—Behcet's disease	0.000598	0.00135	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—HLA-B—Behcet's disease	0.000594	0.00134	CbGpPWpGaD
Afatinib—LCK—Hemostasis—APOB—Behcet's disease	0.000587	0.00132	CbGpPWpGaD
Afatinib—EGFR—Immune System—ITGAL—Behcet's disease	0.000581	0.00131	CbGpPWpGaD
Afatinib—BLK—Immune System—HLA-B—Behcet's disease	0.00058	0.0013	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000576	0.0013	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—APOA1—Behcet's disease	0.000564	0.00127	CbGpPWpGaD
Afatinib—LCK—Immune System—ITGAL—Behcet's disease	0.00056	0.00126	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—TNF—Behcet's disease	0.000545	0.00123	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—HLA-B—Behcet's disease	0.000508	0.00114	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—TNF—Behcet's disease	0.000503	0.00113	CbGpPWpGaD
Afatinib—ERBB2—Immune System—ICAM1—Behcet's disease	0.000497	0.00112	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000493	0.00111	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000492	0.00111	CbGpPWpGaD
Afatinib—ERBB4—Immune System—ICAM1—Behcet's disease	0.00049	0.0011	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—HLA-B—Behcet's disease	0.000489	0.0011	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—HLA-B—Behcet's disease	0.000488	0.0011	CbGpPWpGaD
Afatinib—ERBB2—Disease—APOA1—Behcet's disease	0.000483	0.00109	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—TNF—Behcet's disease	0.000476	0.00107	CbGpPWpGaD
Afatinib—ERBB4—Disease—APOA1—Behcet's disease	0.000476	0.00107	CbGpPWpGaD
Afatinib—BLK—Immune System—ICAM1—Behcet's disease	0.000471	0.00106	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—HLA-B—Behcet's disease	0.00047	0.00106	CbGpPWpGaD
Afatinib—ABL1—Immune System—CTLA4—Behcet's disease	0.000468	0.00105	CbGpPWpGaD
Afatinib—LCK—Hemostasis—APOA1—Behcet's disease	0.000465	0.00105	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—SERPINE1—Behcet's disease	0.000448	0.00101	CbGpPWpGaD
Afatinib—IRAK1—Immune System—HLA-B—Behcet's disease	0.000442	0.000995	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCR1—Behcet's disease	0.000438	0.000985	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—NOS3—Behcet's disease	0.000428	0.000963	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—APOB—Behcet's disease	0.000427	0.000962	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCR1—Behcet's disease	0.000422	0.000949	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—APOB—Behcet's disease	0.000421	0.000948	CbGpPWpGaD
Afatinib—EGFR—Immune System—CTLA4—Behcet's disease	0.0004	0.0009	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—ICAM1—Behcet's disease	0.000396	0.000892	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.00039	0.000877	CbGpPWpGaD
Afatinib—LCK—Immune System—CTLA4—Behcet's disease	0.000385	0.000867	CbGpPWpGaD
Afatinib—ERBB2—Disease—SERPINE1—Behcet's disease	0.000383	0.000863	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—ICAM1—Behcet's disease	0.000382	0.000859	CbGpPWpGaD
Afatinib—ERBB4—Disease—SERPINE1—Behcet's disease	0.000378	0.00085	CbGpPWpGaD
Afatinib—LCK—Hemostasis—SERPINE1—Behcet's disease	0.000369	0.00083	CbGpPWpGaD
Afatinib—ERBB2—Disease—NOS3—Behcet's disease	0.000366	0.000824	CbGpPWpGaD
Afatinib—ERBB4—Disease—NOS3—Behcet's disease	0.000361	0.000811	CbGpPWpGaD
Afatinib—IRAK1—Immune System—ICAM1—Behcet's disease	0.000359	0.000809	CbGpPWpGaD
Afatinib—LCK—Hemostasis—NOS3—Behcet's disease	0.000352	0.000793	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-B—Behcet's disease	0.000346	0.000779	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—APOA1—Behcet's disease	0.000338	0.000761	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—APOA1—Behcet's disease	0.000333	0.00075	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—APOB—Behcet's disease	0.000309	0.000695	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-B—Behcet's disease	0.000296	0.000666	CbGpPWpGaD
Afatinib—EGFR—Disease—APOB—Behcet's disease	0.000295	0.000664	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-B—Behcet's disease	0.000285	0.000641	CbGpPWpGaD
Afatinib—LCK—Disease—APOB—Behcet's disease	0.000284	0.00064	CbGpPWpGaD
Afatinib—ABL1—Immune System—ICAM1—Behcet's disease	0.000281	0.000633	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TNF—Behcet's disease	0.000269	0.000606	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—SERPINE1—Behcet's disease	0.000268	0.000604	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000266	0.000599	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—SERPINE1—Behcet's disease	0.000264	0.000595	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NOS3—Behcet's disease	0.000256	0.000577	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NOS3—Behcet's disease	0.000252	0.000568	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000248	0.000559	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—APOA1—Behcet's disease	0.000245	0.00055	CbGpPWpGaD
Afatinib—EGFR—Immune System—ICAM1—Behcet's disease	0.00024	0.000541	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CAT—Behcet's disease	0.000238	0.000535	CbGpPWpGaD
Afatinib—EGFR—Disease—APOA1—Behcet's disease	0.000233	0.000525	CbGpPWpGaD
Afatinib—LCK—Immune System—ICAM1—Behcet's disease	0.000232	0.000521	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—APOB—Behcet's disease	0.000231	0.000519	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TNF—Behcet's disease	0.00023	0.000518	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CXCL8—Behcet's disease	0.000227	0.000512	CbGpPWpGaD
Afatinib—LCK—Disease—APOA1—Behcet's disease	0.000225	0.000506	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CXCL8—Behcet's disease	0.000224	0.000504	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000211	0.000474	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—APOB—Behcet's disease	0.000207	0.000465	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—APOB—Behcet's disease	0.000199	0.000448	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—SERPINE1—Behcet's disease	0.000194	0.000437	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CXCL8—Behcet's disease	0.000186	0.000419	CbGpPWpGaD
Afatinib—EGFR—Disease—SERPINE1—Behcet's disease	0.000185	0.000417	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NOS3—Behcet's disease	0.000185	0.000417	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—APOA1—Behcet's disease	0.000183	0.000411	CbGpPWpGaD
Afatinib—LCK—Disease—SERPINE1—Behcet's disease	0.000179	0.000402	CbGpPWpGaD
Afatinib—EGFR—Disease—NOS3—Behcet's disease	0.000177	0.000398	CbGpPWpGaD
Afatinib—LCK—Disease—NOS3—Behcet's disease	0.000171	0.000384	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CXCL8—Behcet's disease	0.000164	0.00037	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—APOA1—Behcet's disease	0.000164	0.000368	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—APOA1—Behcet's disease	0.000158	0.000355	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—NOS3—Behcet's disease	0.000138	0.000311	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SERPINE1—Behcet's disease	0.00013	0.000292	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CAT—Behcet's disease	0.000128	0.000289	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SERPINE1—Behcet's disease	0.000125	0.000281	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—APOB—Behcet's disease	0.000125	0.000281	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NOS3—Behcet's disease	0.000124	0.000279	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NOS3—Behcet's disease	0.000119	0.000269	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCL8—Behcet's disease	0.00011	0.000247	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCL8—Behcet's disease	0.000106	0.000238	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—APOA1—Behcet's disease	9.87e-05	0.000222	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—NOS3—Behcet's disease	7.48e-05	0.000168	CbGpPWpGaD
